211 related articles for article (PubMed ID: 11536046)
1. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
4. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
6. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
7. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
Wang D; Russell J; Xu H; Johnson DG
Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
10. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
12. The proliferative and apoptotic activities of E2F1 in the mouse retina.
Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
[TBL] [Abstract][Full Text] [Related]
13. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
14. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott MJ; Dong YB; Yang H; McMasters KM
Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
[TBL] [Abstract][Full Text] [Related]
15. Omomyc expression in skin prevents Myc-induced papillomatosis.
Soucek L; Nasi S; Evan GI
Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
[TBL] [Abstract][Full Text] [Related]
16. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
Schuldiner O; Benvenisty N
Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
[TBL] [Abstract][Full Text] [Related]
17. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation.
Berton TR; Mitchell DL; Guo R; Johnson DG
Oncogene; 2005 Apr; 24(15):2449-60. PubMed ID: 15735727
[TBL] [Abstract][Full Text] [Related]
18. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
19. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
20. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
Agger K; Santoni-Rugiu E; Holmberg C; Karlström O; Helin K
Oncogene; 2005 Jan; 24(5):780-9. PubMed ID: 15531911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
